Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.
Headache|February 9, 2022
Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendationsStewart J Tepper, Huma U Sheikh, Carrie O Dougherty, et al.
Cephalalgia : an International Journal of Headache|June 28, 2019
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysisIlse F de Coo, Juana Ca Marin, Stephen D Silberstein, et al.
Headache|May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysisMessoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
Neurology|December 20, 2019
Vascular safety of erenumab for migraine preventionDavid Kudrow, Julio Pascual, Paul K Winner, et al.
Neurology|March 26, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION TrialRigmor Højland Jensen, Christofer Lundqvist, Henrik W Schytz, et al.
Cephalalgia : an International Journal of Headache|May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trialStewart J Tepper, Henrik W Schytz, Rigmor H Jensen, et al.
The Journal of Headache and Pain|June 13, 2026
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trialHenrik W Schytz, Rigmor H Jensen, Christofer Lundqvist, et al.
JAMA Neurology|September 16, 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled TrialStewart J Tepper, David W Dodick, Michel Lanteri-Minet, et al.
Headache|November 23, 2019
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient CohortTodd J Schwedt, Kathleen Digre, Stewart J Tepper, et al.
Pageof 21